Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API’s), Pharma Intermediates, Specialty Chemicals as well as Formulations.
Financial Results:
Aarti Drugs Ltd reported Revenues for Q4FY24 of ₹620.00 Crores down from ₹742.00 Crore year on year, a fall of 16.44%.
Total Expenses for Q4FY24 of ₹557.00 Crores down from ₹670.00 Crores year on year, a fall of 16.87%.
Consolidated Net Profit of ₹47.00 Crores down 16.07% from ₹56.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹5.15, down 15.02% from ₹6.06 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.